Organ Preservation Solution Market - By Solution (University of Wisconsin, Custodiol HTK, Perfadex, Celsior), Preservation Type (Static Cold Storage, Hypothermic, Normothermic), Organ (Kidney, Liver, Lungs), End-user, Global Forecast (2023-2032)

Organ Preservation Solution Market - By Solution (University of Wisconsin, Custodiol HTK, Perfadex, Celsior), Preservation Type (Static Cold Storage, Hypothermic, Normothermic), Organ (Kidney, Liver, Lungs), End-user, Global Forecast (2023-2032)

Organ Preservation Solution Market Size

Organ Preservation Solution Market size was valued at USD 256.1 million in 2022 and is expected to grow at a CAGR of over 6.8% from 2023 to 2032. The major factors attributing to the growth of this market are increasing number of organ transplantation procedure, and rising healthcare investments.
 

Also, the advancements in preservation techniques, and rising awareness pertaining to the importance of organ donation will further augment the growth of this market. For, instance, according to the United Network of Organ Sharing, in U.S. 42,887 organ transplants were performed in 2022, nearly 3.7% of increase over 2021. Thus, usage of preservation solution owing to such organ transplant procedures is expected to spur the market expansion.
 

Organ preservation solutions are specially designed solutions used to protect and preserve organs outside of the body for transplantation or other medical purposes. These solutions/organ care products are crucial for maintaining the viability and function of organs between their removal from a donor to transplantation into a recipient.

COVID-19 Impact

The organ preservation solution market was significantly impacted by the COVID-19 pandemic. The pandemic has led to disruptions in healthcare systems worldwide, affecting elective procedures, including organ transplantation and supply chain. Many transplant centers had to prioritize resources for COVID-19 patients, leading to a temporary decline in transplant procedures including HLA typing for transplant. Moreover, the decreased availability of donors during the pandemic has directly affected the necessity for organ preservation solutions.
 

Organ Preservation Solution Market Trends

• The rising prevalence of chronic diseases, such as kidney disease, liver disease, and heart failure, has led to an increased need for organ transplants. Chronic diseases can progress to end-stage conditions where organ transplantation becomes a life-saving intervention.
   
• Therefore, increasing demand for solid organ transplantations is driving the market. For instance, according to U.S department of Health and Human Services, around 92 transplants occur in U.S. each day. Similarly, as per the Global Observatory on Donation & Transplantation (GODT) report, in 2020, nearly 39,916 organ transplants have been performed in U.S. Among these transplants, approximately 31.5% of the organs were donated by deceased donors, while 78.5% of donations were done by living donors.
   
• Thus, increasing number of solid organ transplants will significantly drive the market growth.
   

Organ Preservation Solution Market Analysis

Based on solution, the market is classified into University of Wisconsin solution (UW), custodiol HTK solution, perfadex solution, steen solution, celsior solution, hypothermosol solution, and other solutions. The university of Wisconsin solution (UW) segment accounted for 38.2% business share in 2022.
 

• UW solution has a long history of use and has been widely adopted as a standard preservation solution for various organs, including kidneys, livers, and pancreas. Its proven efficacy in maintaining organ viability during static cold storage has established it as a reliable choice for transplantation procedures.
   
• Also, the widespread availability of UW solution, along with established distribution networks, facilitates its accessibility to transplantation centers. Such aforementioned factors contributes to the highest growth of this segment. 

Based on preservation type, the organ preservation solution market is categorized into static cold storage, hypothermic machine perfusion, and normothermic machine perfusion. The static cold storage segment dominated the market and is expected to reach USD 297.3 million by 2032.
 

• Static cold storage has been the traditional and widely used method for organ preservation for several decades. Its long history of successful application has established it as a trusted and proven method in the field of transplantation. This is a relatively simple and cost-effective method compared to alternative preservation techniques. Therefore, the simplicity of the procedure makes it accessible to a wide range of healthcare facilities, including those with limited resources, thereby augmenting the segment demand.

Based on organ, the organ preservation solution market is segmented into kidneys, liver, lungs, heart, and other organs. The kidney segment held highest business share in 2022 and is projected to witness growth at 7%.
 

• Kidney transplantation is one of the most common and widely performed organ transplant procedures globally. The prevalence of end-stage renal diseases, often caused by conditions such as diabetes and hypertension, contributes to a high demand for kidney transplants.
   
• Further, it is noted that the kidney transplants generally showed a favorable long-term survival outcomes for recipients. The positive outcomes and improvement in the quality of life for kidney transplant recipients contribute to the continued demand for kidney transplants. These factors collectively aid in propelling the industry landscape.
   

Based on end-user, the organ preservation solution market is divided into organ transplant, hospitals, and other end-users. The organ transplant centers segment held significant market share and was valued at USD 134.2 million in 2022.
 

• Organ transplant centers serve as central hubs for organ procurement, preservation, and transplantation. They often have established protocols and standardized procedures for the use of organ preservation solutions. The centralized nature of procurement and usage contributes to a concentrated market share.
   
• Also, they accumulate extensive clinical experience through the performance of numerous transplant procedures. Their track record of successful outcomes, including graft survival rates and patient outcomes, contributes to their credibility and leadership in the adoption of specific organ preservation solutions.

The North America organ preservation solution market size in 2022 was USD 103 million and is anticipated to reach USD 196.5 million over the analysis period.
 

• North America boasts a well-developed and advanced healthcare infrastructure, including state-of-the-art transplant centers, research facilities, and medical institutions. This infrastructure supports the adoption of cutting-edge organ preservation solutions and contributes to the region's dominant market share.
   
• Moreover, the region experiences a relatively high incidence of organ transplant procedures, including kidney, liver, heart, and lung transplants.
   

Organ Preservation Solution Market Share

The market is witnessing intense competition with diverse range of players aiming to innovate, enhance product offerings, and expand their global footprint. Waters Medical Systems LLC, Xvivo Perfusion AB, Transmedics, Inc. are prominent players in this market. Market players are vying for a competitive edge by addressing the evolving needs of organ transplantation and offering solutions that enhance organ viability, ease of use, and patient outcomes.
 

Market players operating in the organ preservation solution industry are as mentioned below

• Waters Medical Systems LLC
• Xvivo Perfusion AB
• Transmedics, Inc.
• Preservation Solutions, Inc.
• Paragonix Technologies, Inc.
• Organox Limited
• Dr. Franz Koehler Chemie GmbH
• Accord Healthcare Inc.
• 21st Century Medicine Inc.
• Shanghai Genext Medical Technology
• Bridge to Life Ltd.
• Transplant Biomedicals
   

Organ Preservation Solution Industry News

• In 2021, Paragonix Technologies launched the LIVERguard Donor Live preservation system in both U.S. and Europe region. This strategy is expected to expand company’s product offerings and strengthen their geographic presence.
   
• In August 2019, the Perfadex Plus of Xvivo Perfusion AB received patent approval from European patent authority. This approval has helped the company to outreach to untapped economies.
   

The organ preservation solution market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments

Click here to Buy Section of this Report

By Solution, 2018 – 2032 (USD Million)

• University of Wisconsin solution (UW)
• Custodiol HTK solution
• Perfadex solution
• Steen solution
• Celsior solution
• Hypothermosol solution
• Other solutions

By Preservation Type, 2018 – 2032 (USD Million)

• Static cold storage
• Hypothermic machine perfusion
• Normothermic machine perfusion

By Organ, 2018 – 2032 (USD Million)

• Kidneys
• Liver
• Lungs
• Heart
• Other organs

By End-user, 2018 – 2032 (USD Million)

• Organ transplant centers
• Hospitals
• Other end-users

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of Middle East & Africa